Novel markers of subclinical disease for Ewing family tumors from gene expression profiling
Academic Article
Overview
MeSH Major
Biomarkers, Tumor
Sarcoma, Ewing
abstract
This gene expression array-based approach identified novel markers that may be informative at diagnosis for risk group assessment. Their clinical utility needs to be tested in large patient cohorts.
